主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
VSTM
#2622
Verastem, Inc.
5.7
2
+1.42%
版块:
基础:
利润货币:
日范围
年范围
日变化
+1.42%
每月变动
-11.86%
6个月变化
-38.49%
年变化
+6.32%
前一天收盘价
5.6
4
Open
5.7
2
Bid
Ask
Low
5.7
2
High
5.7
2
交易量
58
市场
股票
医疗保健
VSTM
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
44.51 M
51.49 M
54.95 M
61.55 M
66.78 M
—
Valuation ratios
Enterprise value
19.9 M
177.37 M
213.77 M
91.09 M
451.93 M
934.16 M
Price to earnings ratio
—
-1.41
-1.79
-1.13
-2
-6.34
Price to sales ratio
8.03
18.46
14.85
63.8
36.92
134.03
Price to cash flow ratio
0.71
1.76
1.88
1.56
3.59
8.8
Price to book ratio
0.65
-6.39
-17.08
-7.89
-7.89
-39.24
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.19
0.64
0.4
0.13
0.56
1.72
Return on equity %
2.17
2.23
1.61
0.72
6.35
10.91
Return on invested capital %
1 018.92
1 043.91
2 007.91
967.24
602.43
4 621.49
Gross margin %
—
—
100
94.01
97.33
—
Operating margin %
—
—
2 419.17
2 047.92
362.17
—
EBITDA margin %
—
—
—
-2 027.09
-344.72
—
Net margin %
—
—
2 853.4
1 213.57
876.34
—
Liquidity ratios
Quick ratio
—
—
—
3.44
2.55
—
Current ratio
3.23
3.07
3.5
3.46
2.58
12.61
Inventory turnover
—
—
—
0.03
0.2
—
Asset turnover
0
0
0.02
0.01
0.06
0.09
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.24
0.4
0.54
0.38
0.44
1.76
Long term debt to total equity ratio
2.77
1.41
2.2
2.06
5.03
10.71
Per share metrics
Operating cash flow per share
0.59
0.7
0.71
0.44
0.5
2.35
EBIT per share
—
—
—
-0.59
-0.54
—
EBITDA per share
—
—
—
-0.59
-0.53
—
Total debt per share
—
—
—
—
—
—
Cash per share
2.81
2.49
2.17
2.22
1.88
8.76
Net current asset value per share
3
2.66
2.3
2.35
2.11
9.42
Tangible book value per share
0.27
0.81
0.6
0.28
-0.02
1.67
Working capital per share
2.07
1.79
1.64
1.67
1.29
6.4
Book value per share
0.27
0.81
0.6
0.49
0.21
2.11
Verastem Inc
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.
新闻
What Makes Verastem (VSTM) a New Buy Stock
Verastem Stock Rises Nearly 8% on Strong Q4 & 2025 Preliminary Results
B.Riley重申Verastem股票买入评级,维持16美元目标价
B.Riley reiterates Buy rating on Verastem stock, maintains $16 target
Verastem报告癌症治疗第四季度收入达1750万美元
Verastem reports $17.5 million in Q4 revenue for cancer treatment
Verastem stock rating initiated at Buy by H.C. Wainwright with $18 target
Immuneering: Strong Buy Despite Decline In Share Price On Atebimetinib Data (NASDAQ:IMRX)
Revolution Medicines stock surges over 20% on potential AbbVie acquisition
艾伯维或收购Revolution Medicines,后者股价飙升超20%
What's Going On With Verastem Stock Friday? - Verastem (NASDAQ:VSTM)
Verastem股票稳定 Mizuho重申"优于大盘"评级